CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies ; volume:41 ; number:1 ; day:30 ; month:4 ; year:2022 ; pages:1-16 ; date:12.2022
Journal of experimental & clinical cancer research ; 41, Heft 1 (30.4.2022), 1-16, 12.2022
- Creator
-
Bruno, Samantha
Ghelli Luserna di Rorà, Andrea
Napolitano, Roberta
Soverini, Simona
Martinelli, Giovanni
Simonetti, Giorgia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-022-02363-9
- URN
-
urn:nbn:de:101:1-2022071011012966232447
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
21.09.2026, 3:12 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bruno, Samantha
- Ghelli Luserna di Rorà, Andrea
- Napolitano, Roberta
- Soverini, Simona
- Martinelli, Giovanni
- Simonetti, Giorgia
- SpringerLink (Online service)
Other Objects (12)
BCL-2 as therapeutic target for hematological malignancies
Deubiquitinases in hematological malignancies
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
BCL-2 as therapeutic target for hematological malignancies
Deubiquitinases in hematological malignancies
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
BCL-2 as therapeutic target for hematological malignancies
Deubiquitinases in hematological malignancies
The role of proteostasis in hematological malignancies and the therapeutic implications
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting immune checkpoints in hematological malignancies